about
The search for enhanced therapeutic index in breast cancer: targeting the tumor and modulation of enzyme expression.Quantitative determination of irinotecan and the metabolite SN-38 by nanoflow liquid chromatography-tandem mass spectrometry in different regions of multicellular tumor spheroids.Camptothecins in clinical development.Caspase-mediated pro-apoptotic interaction of panaxadiol and irinotecan in human colorectal cancer cells.Herbal medicines as adjuvants for cancer therapeutics.Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II studySurefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial.Function of AP2/ERF Transcription Factors Involved in the Regulation of Specialized Metabolism in Ophiorrhiza pumila Revealed by Transcriptomics and Metabolomics.RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines.Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy.
P2860
Q35004485-A008946D-F5FB-4978-96E1-F2A859FD94ECQ35181116-F34D0404-1D8B-4239-8B8D-83A1FC0FDB20Q35688238-B9D6FA8F-83FA-4259-B5AD-7CC3F7E87906Q35950062-BC45588F-D5CB-464F-8376-BA394EFCCA98Q36154035-F16BDEC1-EE02-48B3-AD42-D4B7C1729C39Q36616523-960FAEEC-F3A5-4A68-B72E-4A8E0E062F27Q37367343-FEB8921C-D238-4CAB-88D8-DE12F79E2169Q37486781-51D454E6-66B6-42D1-8F92-035B0AE2C545Q41138517-919900BE-FADC-4FAE-B6D5-C034686BD6CDQ46113149-B13BCF3A-D501-4735-90E8-390AA40E621FQ50017359-7236937C-688B-401E-A7DA-349DC8AF0061
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Optimizing the use of irinotecan in colorectal cancer.
@ast
Optimizing the use of irinotecan in colorectal cancer.
@en
Optimizing the use of irinotecan in colorectal cancer.
@nl
type
label
Optimizing the use of irinotecan in colorectal cancer.
@ast
Optimizing the use of irinotecan in colorectal cancer.
@en
Optimizing the use of irinotecan in colorectal cancer.
@nl
prefLabel
Optimizing the use of irinotecan in colorectal cancer.
@ast
Optimizing the use of irinotecan in colorectal cancer.
@en
Optimizing the use of irinotecan in colorectal cancer.
@nl
P2093
P1433
P1476
Optimizing the use of irinotecan in colorectal cancer.
@en
P2093
E Van Cutsem
U Vanhoefer
P356
10.1634/THEONCOLOGIST.6-SUPPL_4-17
P478
P577
2001-01-01T00:00:00Z